$76.78
+2.33 (+3.13%)
JBSS News3 articles
Johnson & Johnson Shares Dip in Extended Trading Amid Healthcare Sector Weakness
Johnson & Johnson stock declined 0.6% in after-hours trading Monday as healthcare stocks underperformed the broader market. The company faces ongoing talc litigation and will present at an industry conference next month.
Johnson & Johnson Shares Retreat Amid Healthcare Sector Weakness
Johnson & Johnson stock declined 1.1% as healthcare stocks underperformed the broader market. Traders are eyeing upcoming U.S. jobs and inflation data for direction.
Johnson & Johnson Stock Nears 52-Week High Amid Legal and Medical Device Updates
Johnson & Johnson shares approached a 52-week high as a New Jersey court disqualified a plaintiffs' firm from talc cases and the company reported positive pilot data for its atrial fibrillation platform.